Medicare Enrolled
Dr. Jigar Shah, M.D.
Hospitalist Physician · Margate, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Jigar Shah is a hospitalist physician in Margate, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 88,903 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Shah received a total of $563,100 from 53 pharmaceutical and/or device companies across 1211 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 0% volume in FL
$563,100 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 113940 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗88,903
Medicare services
Top 0% in FL for hospitalist physician
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
36,800 | $4 | $13 |
| Tocilizumab injection (Actemra) | 23,873 | $4 | $7 |
| Romosozumab injection (Evenity) for osteoporosis | 19,320 | $8 | $26 |
| Denosumab injection (Prolia/Xgeva) | 6,420 | $17 | $33 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
491 | $100 | $270 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
420 | $59 | $187 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
310 | $0 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
245 | $70 | $184 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
231 | $107 | $345 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
167 | $23 | $110 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
103 | $1 | $1 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
97 | $125 | $415 |
| Injection, methylprednisolone acetate, 40 mg | 82 | $6 | $30 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
71 | $13 | $85 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
69 | $4 | $60 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
64 | $81 | $233 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
60 | $23 | $67 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
36 | $53 | $175 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $142 | $364 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $78 | $273 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.4% high complexity
98.6% medium
1.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$563,100
Total received (2018-2024)
Avg $80,443/year across 7 years
Top 0% in FL for hospitalist physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
1,211
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$165,952
2023
$116,591
2022
$128,058
2021
$60,386
2020
$21,732
2019
$42,179
2018
$28,202
Payments by company (2024)
Amgen Inc.
$100,472
GlaxoSmithKline, LLC.
$36,069
AstraZeneca Pharmaceuticals LP
$27,671
UCB, Inc.
$379
ABBVIE INC.
$325
PFIZER INC.
$260
Radius Health, Inc.
$119
Mallinckrodt Hospital Products Inc.
$72
Aurinia Pharma U.S., Inc.
$72
ANI Pharmaceuticals, Inc.
$62
Kiniksa Pharmaceuticals International, plc
$61
Fresenius Kabi USA, LLC
$50
SOBI, INC
$44
GENZYME CORPORATION
$39
SCILEX PHARMACEUTICALS INC.
$39
Lilly USA, LLC
$30
DePuy Synthes Sales Inc.
$28
Organon Llc
$25
Actelion Pharmaceuticals US, Inc.
$25
Biocon Biologics Inc
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Janssen Biotech, Inc.
$22
Teva Pharmaceuticals USA, Inc.
$19
Novartis Pharmaceuticals Corporation
$19
Top 3 companies account for 99.0% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$203,976
GlaxoSmithKline, LLC.
$131,562
Amgen Inc.
$101,768
AstraZeneca Pharmaceuticals LP
$82,172
Horizon Pharma plc
$22,769
Aurinia Pharma U.S., Inc.
$5,055
OraPharma, a division of Bausch Health US, LLC
$4,174
Janssen Biotech, Inc.
$1,714
AbbVie, Inc.
$1,408
UCB, Inc.
$1,051
Biogen, Inc.
$1,019
ABBVIE INC.
$698
Mallinckrodt Hospital Products Inc.
$668
Radius Health, Inc.
$625
AbbVie Inc.
$552
PFIZER INC.
$514
Novartis Pharmaceuticals Corporation
$503
Lilly USA, LLC
$437
Genentech USA, Inc.
$256
Actelion Pharmaceuticals US, Inc.
$171
E.R. Squibb & Sons, L.L.C.
$167
ANI Pharmaceuticals, Inc.
$147
GENZYME CORPORATION
$138
Mallinckrodt LLC
$134
Organon LLC
$123
SOBI, INC
$102
Mallinckrodt Enterprises LLC
$91
Kiniksa Pharmaceuticals, Ltd.
$80
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
Fresenius Kabi USA, LLC
$72
Celgene Corporation
$66
Novo Nordisk Inc
$65
Kiniksa Pharmaceuticals International, plc
$61
Merck Sharp & Dohme Corporation
$60
Acclarent, Inc
$57
MML US, Inc.
$50
Mylan Institutional Inc.
$48
Flexion Therapeutics, Inc.
$46
DePuy Synthes Sales Inc.
$46
SCILEX PHARMACEUTICALS INC.
$39
Sandoz Inc.
$37
Teva Pharmaceuticals USA, Inc.
$36
SANOFI-AVENTIS U.S. LLC
$34
MEDEXUS PHARMA, INC.
$31
Bioventus LLC
$30
Alvogen Inc
$27
Organon Llc
$25
Biocon Biologics Inc
$25
Exeltis, USA Inc.
$24
Octapharma USA, Inc.
$20
Ultragenyx Pharmaceutical Inc.
$19
FIDIA PHARMA USA INC.
$16
TerSera Therapeutics LLC
$14
Top 3 companies account for 77.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUEXIS · Durolane · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · HYRIMOZ · Hulio · Humira · IDACIO · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · NEUTRASAL · NuDyn · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · QMIIZ ODT · RAYOS · RELIEVA SPINPLUS Balloon Sinuplasty System · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · ReActiv8 · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · SYNVISC-ONE · TALTZ · TAVNEOS · TEPEZZA · TERIPARATIDE · TREMFYA · Tavneos · Truxima · Tymlos · UPLIZNA · VIMOVO · XELJANZ · ZTLido · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hospitalist physicians in nearby ZIP areas
97
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA NORTHWEST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shah is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Shah performed 36,800 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $563,100 from 53 companies across 1,211 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other hospitalist physicians in Margate?
Dr. Shah's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hospitalist Physicians in Margate
Browse hospitalist physicians in Margate ranked by procedure volume and transparency data.
Highest volume
Top Hospitalist Physicians in FL
Hospitalist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hospitalist Physicians in FL
Which FL hospitalist physicians receive the most from drug and device companies.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology